ArticleThe international journal of cardiovascular imaging2026
Optimizing coronary CT angiography with spectral dual-layer CT: motion-compensated virtual monoenergetic imaging achieves 50% contrast dose reduction in a phantom study.
Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Improving image quality by reducing breathing artifacts in CT of patients early after coronary artery bypass graft surgery.The international journal of cardiovascular imaging · 2026Article
- Contrast dose determined by body weight and tube potential in coronary CT angiography improves attenuation consistency and reduces contrast dose.European journal of radiology open · 2026Article
- Comparison of deep learning reconstruction and iterative reconstruction algorithms for virtual monoenergetic image quality in overweight and obese patients with triple-low scan protocol dual-energy carotid computed tomography angiography.Quantitative imaging in medicine and surgery · 2026Article
- Spectral computed tomography characterization of coronary atherosclerotic plaque: principles, imaging biomarkers, and clinical significance.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reduced contrast media (CM) dose at elevated heart rates (HRs) poses a challenge for coronary artery disease (CAD) assessment. Using a dynamic phantom, we evaluated the performance of a vendor-specific coronary motion-compensated reconstruction (MCR) at various simulated HRs and reduced CM dose in low virtual monoenergetic images (VMIs) from coronary computed tomography angiography (CCTA). A clinical CCTA protocol was used to image a 5-mm artificial coronary artery, filled with 100% (400 Hounsfield units (HU)) and 50% CM dose, using a robotic arm for translation at six velocities (0-50 mm/s, 10 mm/s steps). Conventional images and VMIs (40-70 keV, 10 keV steps) were reconstructed without and with MCR. The study evaluated the MCR influence on motion area and contrast-to-noise ratio (CNR) of the resulting segmented arteries (motion area), with the static conventional reconstructed artery at 100% CM dose as the reference, and non-overlapping 95% confidence intervals with the reference indicating significant differences. At 50% CM dose, motion area increased significantly (up to 50%) at elevated velocities (≥ 30 mm/s) without MCR, while no significant variations were observed with MCR. Additionally, without MCR, VMIs exhibited significant CNR decreases (up to 65%) at velocities ≥ 30 mm/s. Only the combination of MCR and 40 keV VMI achieved CNR comparable to the reference, regardless of HR. The combination of MCR with low VMIs enables 50% CM dose reduction, with similar motion area and CNR when compared to conventional CCTA with 100% CM dose. These parameter settings can potentially be used to optimize low CM dose CCTA at higher HRs.
Indexed as
Identifiers
41201710What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.